News on Hepatitis continually updated from thousands of sources around the net.
1 hr ago | Worcester Telegram & Gazette
Eric von Hofe is preparing the two-person company Antigen Express Inc. for a review of data from studies of a breast cancer vaccine.
Do You Know the NRA?
Should we change our lifestyles to help reduce global warming?
What do Mickey Mantle, Evel Knievel, Naomi Judd, Pamela Anderson, Jim Nabors and Keith Richards have in common? They have all faced hepatitis C. And they are not the only ones; about 3.2 million Americans have chronic hepatitis C. It claims the lives of more people each year than HIV/AIDS and is the leading cause of liver transplants in the United ... (more)
AIDS Healthcare Foundation , the nation's largest HIV/AIDS nonprofit medical provider, expressed its profound outrage at Gilead Sciences over the price of Sovaldi, its new Hepatitis C drug, which was approved by the Food and Drug Administration on Friday.
New needles like those shown in 2004 photo are available at Tapestry Health's needle exchange program in Holyoke.
U.S. consumers increased their spending in October even though their wages and salaries barely increased, raising questions about how strong the economy will grow at the end of the year.
In clinical trials, the polymerase inhibitor, the first used in hepatitis C treatment, has shown a more than 90 percent success rate in curing the deadly virus that causes liver failure and cancer of the liver .
The U.S. Food and Drug Administration has approved Gilead Sciences' hotly anticipated Sovaldi , a once-daily oral nucleotide analog polymerase inhibitor to treat people with hepatitis C virus , including those coinfected with HIV and those who have liver cancer and are awaiting a transplant.
Sovaldi is the first drug that has been shown to safely and effectively treat certain types of hepatitis C infection without a need for interferon, the FDA said.
A "game changing" new drug with an unprecedented 95% cure rate against the hepatitis C virus was approved by the U.S. Food and Drug Administration on December 6. "The future is looking very bright for people with hepatitis C," said Daniel Raymond, a consumer advocate and Policy Director at the Harm Reduction Coalition .
Sovaldi, a new medication for hepatitis C that can be paired with other drugs to make treatment of the liver-damaging disease faster, easier and more effective, got approval from the Food and Drug Administration Friday.
The Food and Drug Administration approved the pill Sovaldi as a daily treatment in combination with older drugs to treat the major forms of hepatitis C. Current treatments for hepatitis C can take up to a year of therapy and only cure three out of four patients.
Federal health officials have approved a highly anticipated hepatitis C drug from Gilead Sciences Inc. that is expected to offer a faster, more palatable cure to millions of people infected with the liver-destroying virus.
The U.S. Food and Drug Administration has approved a new drug called Sovaldi to treat chronic hepatitis C infections.
Hepatitis C is a virus that has spread throughout the Baby Boomer population and nearly half of those infected don't know they were exposed to it decades ago.
So, you've decided to leave the snow and cold behind and spend a couple of weeks soaking up the tropical sun somewhere.
A new class of oral drugs for curing hepatits C is hitting the markets this winter, displacing injectible predecessors and ushering in treatments that are shorter and in some cases avoid side-affect riddled interferon.
Multiple types of cells are needed for patients to recover from surgery or to restore life to tissues that have lost circulation.